Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?

In light of the number of studies conducted to examine the treatment of cognitive impairment associated with schizophrenia (CIAS), we critically reviewed recent CIAS trials. Trials were identified through searches of the website “www.clinicaltrials.gov” using the terms “schizophrenia AND cognition,”...

Descripción completa

Detalles Bibliográficos
Autores principales: Keefe, Richard S. E., Buchanan, Robert W., Marder, Stephen R., Schooler, Nina R., Dugar, Ashish, Zivkov, Milana, Stewart, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576170/
https://www.ncbi.nlm.nih.gov/pubmed/22114098
http://dx.doi.org/10.1093/schbul/sbr153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576170/
https://www.ncbi.nlm.nih.gov/pubmed/22114098
http://dx.doi.org/10.1093/schbul/sbr153

Ejemplares similares